市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 看涨 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | T2 Biosystems, Inc. | 混合的 | 混合的 |
AIStockmoo 评分
| 价值 40% | -5.0 |
| AI Insight 参考 | NA |
| 相对估值 参考 | NA |
| 财务健康 参考 | -5.0 |
| 时机 40% | 0.0 |
| AI Technical 参考 | NA |
| 技术振荡指标 参考 | 0.0 |
| 技术平均移动指标 参考 | 0.0 |
| 聪明钱 20% | 0.0 |
| 分析师共识 参考 | 0.0 |
| 内部交易活动 参考 | NA |
| 市场环境 | ×1.21 |
| 宏观环境 参考 | -3.3 |
| 行业对比大市 (6个月) | -17.7% |
| 支柱一致性 | ×1.00 |
| 不计入评分 | |
| 价格波动 参考 | NA |
| 最终评分 | -2.42 |
|
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company’s products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Value |
| 内部持股比例 | 8.07% |
| 机构持股比例 | 38.15% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Horizon Financial Services, Llc | 31 Dec 2025 | 9 |
| Union Bancaire Privee, Ubp Sa | 31 Dec 2025 | 1 |
投资组合